Search
for
Sort by
Research 751–780 of 1000+
- Impact of comorbidity burden on mortality in patients with COVID-19: a retrospective analysis of the Korean health insurance database
- Observation and consideration on using of JAKi in clinical trials in times of COVID ‐19
- The effect of sex hormone on COVID-19: analysis of laboratory-confirmed 5061 patients in South Korea
- Use of Finasteride and Spironolactone in Hospitalized COVID-19 Patients and Their Effect on Severity Outcomes
- Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19
- A Systematic Review of Persistent Symptoms and Residual Abnormal Functioning following Acute COVID-19: Ongoing Symptomatic Phase vs. Post-COVID-19 Syndrome
- Inhibition of SARS-CoV-2 entry through the ACE2/TMPRSS2 pathway: a promising approach for uncovering early COVID-19 drug therapies
- Immune mechanisms associated with sex-based differences in severe COVID-19 clinical outcomes
- The Impact of Angiotensin-Converting Enzyme 2 (ACE2) Expression Levels in Patients with Comorbidities on COVID-19 Severity: A Comprehensive Review
- Early Antiandrogen Therapy With Dutasteride Reduces Viral Shedding, Inflammatory Responses, and Time-to-Remission in Males With COVID-19: A Randomized, Double-Blind, Placebo-Controlled Interventional Trial (EAT-DUTA AndroCoV Trial – Biochemical)
- 5‐alpha‐reductase inhibitors are associated with reduced frequency of COVID‐19 symptoms in males with androgenetic alopecia
- Recurrence of cutaneous T‐cell lymphoma post viral vector COVID‐19 vaccination
- Clinical characteristics and outcomes of adult patients admitted with COVID-19 in East London: a retrospective cohort analysis
- Changes in dermatological complaints among healthcare professionals during the COVID-19 outbreak in Turkey
- Sex steroid hormones are associated with mortality in COVID-19 patients
- Roles of existing drug and drug targets for COVID-19 management
- A Review of the Dermatological Manifestations of Coronavirus Disease 2019 (COVID-19)
- Expression of concern: potential risk for developing severe COVID-19 disease among anabolic steroid users
- Testosterone target therapy: focus on immune response, controversies and clinical implications in patients with COVID-19 infection
- Change of the diagnostic distribution in applicants to dermatology after COVID ‐19 pandemic: What it whispers to us?
- Detection of Male Hypogonadism in Patients with Post COVID-19 Condition
- The effect of canakinumab on clinical outcomes in patients with COVID-19: A meta-analysis
- Do Anti-androgens Have Potential as Therapeutics for COVID-19?
- Induced pluripotent stem cells: Generation methods and a new perspective in COVID-19 research
- Weathering the Storm: Harnessing the Resolution of Inflammation to Limit COVID-19 Pathogenesis
- Opportunistic pathogenic fungal co-infections are prevalent in critically ill COVID-19 patients: Are they risk factors for disease severity?
- Patients with bullous skin disease in a high‐epidemic COVID‐19 area, Bergamo, Italy
- Comparison of patients’ diagnoses in a dermatology outpatient clinic during the COVID‐19 pandemic period and pre‐pandemic period
- The impact of individual lifestyle and status on the acquisition of COVID-19: A case—Control study
- Clinical and Laboratory Follow-up After Hospitalization for COVID-19 at an Italian Tertiary Care Center